Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Fragment Based Lead Discovery

Stefan Geschwindner's Biography



Stefan Geschwindner, Principal Scientist, AstraZeneca R&D Molndal

Stefan Geschwindner is a Principal Scientist currently working within Structure, Biophysics and Computational Sciences at AstraZeneca´s R&D site in Mölndal, Sweden. In this role, he is responsible for the implementation and exploitation of label-free methodologies in lead discovery activities. He holds a PhD degree in Biochemistry from University of Frankfurt. Prior to his current position, he was working at the Structural Chemistry department of AstraZeneca in Mölndal, Sweden from 1997 until 2006 where he focused primarily on protein production to secure a high quality protein supply chain with timely delivery into NMR and Crystallography.

Stefan Geschwindner Image

Screening Tactics for Improving the Impact of Fragment Binding Information on the Different Stages of Lead Discovery

Tuesday, 13 March 2012 at 10:00

Add to Calendar ▼2012-03-13 10:00:002012-03-13 11:00:00Europe/LondonScreening Tactics for Improving the Impact of Fragment Binding Information on the Different Stages of Lead Discovery SELECTBIOenquiries@selectbiosciences.com

The presentation will demonstrate available fragment screening methodologies and approaches and how their different information content is being used at the various stages of early lead discovery. This will be illustrated by providing some project examples from different discovery stages.


Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonFragment Based Lead DiscoverySELECTBIOenquiries@selectbiosciences.com